Who We Are
Our Partnerships
Our Products
News
Contact
GlycoMark
More
An FDA-cleared and CE-Marked blood test specific to detecting recent hyperglycemia, glycemic variability, and pancreatic beta-cell mass
Genetic risk assessment of type 2 diabetes
A new genetic test for healthy pregnancy and gestational diabetes
A simple blood test that predicts 1-hour glucose levels (OGTT) and early-phase-beta-cell dysfunction
Diabetes Point-of-Care Diabetes System
Hemoglobin A1c
CRP
U-Albumin
Monitoring glycemic control (preceeding 2-3 weeks) in patients with diabetes
A new-generation test for insulin resistance, metabolic health, and associated complications